NO330802B1 - Metode for gjenvinning av RNA fra formalin-fiksert paraffin-innstopt vevsprove, metode for kvantitativ maling av genekspresjon av et malgen og metode for maling av niva av malgenekspresjon i en fiksert paraffin-innstopt vevsprove. - Google Patents
Metode for gjenvinning av RNA fra formalin-fiksert paraffin-innstopt vevsprove, metode for kvantitativ maling av genekspresjon av et malgen og metode for maling av niva av malgenekspresjon i en fiksert paraffin-innstopt vevsprove. Download PDFInfo
- Publication number
- NO330802B1 NO330802B1 NO20022945A NO20022945A NO330802B1 NO 330802 B1 NO330802 B1 NO 330802B1 NO 20022945 A NO20022945 A NO 20022945A NO 20022945 A NO20022945 A NO 20022945A NO 330802 B1 NO330802 B1 NO 330802B1
- Authority
- NO
- Norway
- Prior art keywords
- rna
- sample
- expression
- approx
- tissue sample
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 93
- 230000014509 gene expression Effects 0.000 title claims description 61
- 238000005259 measurement Methods 0.000 title claims description 4
- 101150108610 MAL gene Proteins 0.000 title 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 83
- 108010022394 Threonine synthase Proteins 0.000 claims description 58
- 102000005497 Thymidylate Synthase Human genes 0.000 claims description 57
- 239000000523 sample Substances 0.000 claims description 49
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- 230000003196 chaotropic effect Effects 0.000 claims description 30
- 238000010438 heat treatment Methods 0.000 claims description 24
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 claims description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- 238000010839 reverse transcription Methods 0.000 claims description 16
- 239000002299 complementary DNA Substances 0.000 claims description 14
- 238000011084 recovery Methods 0.000 claims description 13
- 239000003960 organic solvent Substances 0.000 claims description 12
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 108020004999 messenger RNA Proteins 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 238000001962 electrophoresis Methods 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 238000003752 polymerase chain reaction Methods 0.000 claims description 5
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 238000000265 homogenisation Methods 0.000 claims description 4
- 238000013467 fragmentation Methods 0.000 claims description 3
- 238000006062 fragmentation reaction Methods 0.000 claims description 3
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 3
- -1 guanidinium compound Chemical class 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 2
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 claims description 2
- 239000002751 oligonucleotide probe Substances 0.000 claims description 2
- 238000012869 ethanol precipitation Methods 0.000 claims 1
- 238000010208 microarray analysis Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 62
- 239000000243 solution Substances 0.000 description 39
- 206010028980 Neoplasm Diseases 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 239000012188 paraffin wax Substances 0.000 description 20
- 239000008188 pellet Substances 0.000 description 14
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 12
- 238000010240 RT-PCR analysis Methods 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 12
- 229960002949 fluorouracil Drugs 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 230000004044 response Effects 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 206010009944 Colon cancer Diseases 0.000 description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
- 101150112897 TS gene Proteins 0.000 description 9
- 108010085238 Actins Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 102000007469 Actins Human genes 0.000 description 7
- 206010027476 Metastases Diseases 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 6
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 6
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 6
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 6
- 210000001072 colon Anatomy 0.000 description 6
- 208000029742 colonic neoplasm Diseases 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 230000009401 metastasis Effects 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 238000003753 real-time PCR Methods 0.000 description 6
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000008096 xylene Substances 0.000 description 6
- 102100034343 Integrase Human genes 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- 101710132082 Pyrimidine/purine nucleoside phosphorylase Proteins 0.000 description 5
- 238000002123 RNA extraction Methods 0.000 description 5
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 5
- 102000013537 Thymidine Phosphorylase Human genes 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000012472 biological sample Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 4
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 210000003238 esophagus Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 4
- 235000008191 folinic acid Nutrition 0.000 description 4
- 239000011672 folinic acid Substances 0.000 description 4
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 4
- 230000016507 interphase Effects 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 229960001691 leucovorin Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 108010077895 Sarcosine Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 206010061289 metastatic neoplasm Diseases 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 238000002205 phenol-chloroform extraction Methods 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 229940043230 sarcosine Drugs 0.000 description 3
- 238000001542 size-exclusion chromatography Methods 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 102100022334 Dihydropyrimidine dehydrogenase [NADP(+)] Human genes 0.000 description 2
- 108010066455 Dihydrouracil Dehydrogenase (NADP) Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 2
- JSRLJPSBLDHEIO-SHYZEUOFSA-N dUMP Chemical compound O1[C@H](COP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 JSRLJPSBLDHEIO-SHYZEUOFSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000002055 immunohistochemical effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WAVYAFBQOXCGSZ-UHFFFAOYSA-N 2-fluoropyrimidine Chemical compound FC1=NC=CC=N1 WAVYAFBQOXCGSZ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 101150071146 COX2 gene Proteins 0.000 description 1
- 101100114534 Caenorhabditis elegans ctc-2 gene Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150000187 PTGS2 gene Proteins 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 239000004052 folic acid antagonist Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 208000026037 malignant tumor of neck Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 208000025402 neoplasm of esophagus Diseases 0.000 description 1
- 210000005170 neoplastic cell Anatomy 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000007692 polyacrylamide-agarose gel electrophoresis Methods 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical class CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000002719 pyrimidine nucleotide Substances 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 238000011155 quantitative monitoring Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000006485 reductive methylation reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/469,338 US6248535B1 (en) | 1999-12-20 | 1999-12-20 | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
PCT/US2000/030012 WO2001046402A1 (en) | 1999-12-20 | 2000-10-31 | Method for isolation of rna from formalin-fixed paraffin-embedded tissue specimens |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20022945D0 NO20022945D0 (no) | 2002-06-19 |
NO20022945L NO20022945L (no) | 2002-08-06 |
NO330802B1 true NO330802B1 (no) | 2011-07-18 |
Family
ID=23863395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022945A NO330802B1 (no) | 1999-12-20 | 2002-06-19 | Metode for gjenvinning av RNA fra formalin-fiksert paraffin-innstopt vevsprove, metode for kvantitativ maling av genekspresjon av et malgen og metode for maling av niva av malgenekspresjon i en fiksert paraffin-innstopt vevsprove. |
Country Status (20)
Country | Link |
---|---|
US (8) | US6248535B1 (de) |
EP (3) | EP1242594B1 (de) |
JP (1) | JP2003525033A (de) |
KR (1) | KR100723328B1 (de) |
CN (2) | CN1891836B (de) |
AR (1) | AR027036A1 (de) |
AT (2) | ATE349518T1 (de) |
AU (2) | AU784565C (de) |
BR (1) | BR0016569A (de) |
CA (1) | CA2394618C (de) |
DE (1) | DE60032634T2 (de) |
DK (1) | DK1743939T3 (de) |
EA (2) | EA008832B1 (de) |
ES (1) | ES2373149T3 (de) |
HK (2) | HK1055446A1 (de) |
IL (2) | IL150116A0 (de) |
MX (1) | MXPA02006145A (de) |
NO (1) | NO330802B1 (de) |
TW (1) | TWI277652B (de) |
WO (1) | WO2001046402A1 (de) |
Families Citing this family (210)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69839963D1 (de) | 1997-08-20 | 2008-10-16 | Univ Miami | Hochqualitatives durchlaufendes verfahren zur fixierung, dehydratisierung, entfettung und imprägnation von geweben |
US6793890B2 (en) | 1997-08-20 | 2004-09-21 | The University Of Miami | Rapid tissue processor |
US6960439B2 (en) | 1999-06-28 | 2005-11-01 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
US6248535B1 (en) * | 1999-12-20 | 2001-06-19 | University Of Southern California | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
US20060166227A1 (en) * | 2000-06-20 | 2006-07-27 | Stephen Kingsmore | Protein expression profiling |
US6582919B2 (en) | 2001-06-11 | 2003-06-24 | Response Genetics, Inc. | Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates |
US7049059B2 (en) * | 2000-12-01 | 2006-05-23 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
ES2394630T3 (es) * | 2000-12-01 | 2013-02-04 | Response Genetics, Inc. | Método de determinación de la expresión génica del receptor del factor de crecimiento epidérmico y HER2-NEU y niveles de correlación de la misma con las tasas de supervivencia |
US20020142328A1 (en) * | 2000-12-01 | 2002-10-03 | Danenberg Kathleen D. | Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors |
US6602670B2 (en) | 2000-12-01 | 2003-08-05 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 expression |
US6518416B1 (en) | 2000-12-01 | 2003-02-11 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 expression |
US6956111B2 (en) | 2001-03-02 | 2005-10-18 | Response Genetics, Inc. | Method of determining dihydropyrimidine dehydrogenase gene expression |
US6686155B2 (en) * | 2001-06-14 | 2004-02-03 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
US20040091857A1 (en) * | 2001-07-20 | 2004-05-13 | Nallur Girish N. | Gene expression profiling |
EP3112025B1 (de) | 2001-10-12 | 2019-11-27 | Becton, Dickinson and Company | Vorrichtung zum transport von biologischen proben |
JP4303592B2 (ja) * | 2001-10-12 | 2009-07-29 | ベクトン・ディキンソン・アンド・カンパニー | 生体試料を輸送する方法及びバスケット装置 |
KR20040064275A (ko) | 2001-11-09 | 2004-07-16 | 소스 프리시전 메디슨, 인코포레이티드 | 유전자 발현 프로파일을 이용한 질병의 동정, 모니터링,치료 및 생물학적 상태의 확인 |
US7553619B2 (en) * | 2002-02-08 | 2009-06-30 | Qiagen Gmbh | Detection method using dissociated rolling circle amplification |
ES2616800T3 (es) | 2002-03-13 | 2017-06-14 | Genomic Health, Inc. | Obtención de perfil de expresión génica en tejidos tumorales biopsiados |
CA2494262A1 (en) | 2002-07-31 | 2004-02-05 | University Of Southern California | Polymorphisms for predicting disease and treatment outcome |
US7364846B2 (en) * | 2002-10-11 | 2008-04-29 | Molecular Devices Corporation | Gene expression profiling from FFPE samples |
CN100374576C (zh) * | 2002-10-11 | 2008-03-12 | 阿克丘勒斯生物科学股份有限公司 | 来自ffpe样品的基因表达分布图 |
US8039218B2 (en) * | 2002-11-14 | 2011-10-18 | John Wayne Cancer Institute | Detection of cancer cells in body fluids |
DK1572105T3 (da) * | 2002-11-14 | 2011-10-17 | Wayne John Cancer Inst | Detektion af mikrometastase af melamoner og brystcancer i paraffinindlejret tumor drænende lymfeknuder ved hjælp af kvantitativ multimaker RT-PCR |
JP4606879B2 (ja) * | 2002-11-15 | 2011-01-05 | ジェノミック ヘルス, インコーポレイテッド | Egfr陽性癌の遺伝子発現プロファイリング |
US9487823B2 (en) | 2002-12-20 | 2016-11-08 | Qiagen Gmbh | Nucleic acid amplification |
US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
ES2314378T3 (es) * | 2003-02-20 | 2009-03-16 | Genomic Health, Inc. | Uso de arn intronico para medir la expresion genica. |
EP1601450B1 (de) | 2003-03-10 | 2013-06-05 | Expression Pathology, Inc. | Flüssiggewebepräparation aus histopathologisch bearbeiteten biologischen proben, geweben und zellen |
US8043834B2 (en) | 2003-03-31 | 2011-10-25 | Qiagen Gmbh | Universal reagents for rolling circle amplification and methods of use |
US7267950B2 (en) * | 2003-05-01 | 2007-09-11 | Veridex, Lcc | Rapid extraction of RNA from cells and tissues |
US20050164218A1 (en) * | 2003-05-30 | 2005-07-28 | David Agus | Gene expression markers for response to EGFR inhibitor drugs |
US20040248103A1 (en) * | 2003-06-04 | 2004-12-09 | Feaver William John | Proximity-mediated rolling circle amplification |
EP3470535B1 (de) * | 2003-06-24 | 2020-04-01 | Genomic Health, Inc. | Vorhersage der wahrscheinlichkeit eines wiederauftretens von krebs |
ES2651849T3 (es) * | 2003-07-10 | 2018-01-30 | Genomic Health, Inc. | Algoritmo del perfil de expresión y test para el pronóstico del cáncer |
US8062897B2 (en) | 2003-07-21 | 2011-11-22 | Aureon Laboratories, Inc. | Diagnostic histopathology using multiplex gene expression FISH |
ATE554166T1 (de) * | 2003-07-25 | 2012-05-15 | Life Technologies Corp | Verfahren und zusammensetzungen zur herstellung von rna aus einer fixierten probe |
US20050059024A1 (en) | 2003-07-25 | 2005-03-17 | Ambion, Inc. | Methods and compositions for isolating small RNA molecules |
US20050042660A1 (en) * | 2003-07-31 | 2005-02-24 | Hall Gerald Edward | Devices and methods for isolating RNA |
EP2216415B2 (de) * | 2003-08-01 | 2017-01-04 | Life Technologies Corporation | Zusammensetzungen und Verfahren zur Aufreinigung kurzer RNA-Moleküle und anderer Nukleinsäuren |
CA2542656A1 (en) * | 2003-10-16 | 2005-05-06 | Genomic Health, Inc. | Qrt-pcr assay system for gene expression profiling |
US7470401B2 (en) * | 2003-10-24 | 2008-12-30 | The University Of Miami | Simplified tissue processing |
MXPA06005424A (es) | 2003-11-13 | 2007-01-25 | Univ Georgia Res Found | Metodos para caracterizar virus de enfermedad bursal infecciosa. |
WO2005064019A2 (en) * | 2003-12-23 | 2005-07-14 | Genomic Health, Inc. | Universal amplification of fragmented rna |
JP5813908B2 (ja) * | 2004-04-09 | 2015-11-17 | ジェノミック ヘルス, インコーポレイテッド | 化学療法剤に対する応答を予測するための遺伝子発現マーカー |
US7794932B2 (en) | 2004-04-16 | 2010-09-14 | Piotr Chomczynski | Reagents and methods for isolation of purified RNA |
WO2005116256A2 (en) * | 2004-04-16 | 2005-12-08 | Wei-Sing Chu | Device for extracting biological molecules from tissue specimens |
US20050239055A1 (en) * | 2004-04-22 | 2005-10-27 | Mariani Brian D | Enterovirus primers and probes |
US7332597B2 (en) * | 2004-06-28 | 2008-02-19 | University Of Kentucky Research Foundation | Primers and probe to identify mycobacterium tuberculosis complex |
AU2005267148A1 (en) | 2004-07-01 | 2006-02-02 | University Of Southern California | Genetic markers for predicting disease and treatment outcome |
US20060099605A1 (en) * | 2004-11-11 | 2006-05-11 | Hall Gerald E Jr | Devices and methods for isolating RNA |
DE102004047772B4 (de) * | 2004-09-30 | 2018-12-13 | Infineon Technologies Ag | Lateraler Halbleitertransistor |
ES2521115T3 (es) | 2004-09-30 | 2014-11-12 | Epigenomics Ag | Método para proveer fragmentos de ADN derivados de una muestra archivada |
CA2585571C (en) * | 2004-11-05 | 2020-01-21 | Genomic Health, Inc. | Predicting response to chemotherapy using gene expression markers |
US7622251B2 (en) * | 2004-11-05 | 2009-11-24 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and prediction of treatment response |
US20060141481A1 (en) * | 2004-12-27 | 2006-06-29 | Mariani Brian D | HSV-1 and HSV-2 primers and probes |
US7541144B2 (en) * | 2005-01-31 | 2009-06-02 | Agilent Technologies, Inc. | RNA labeling method |
US8309303B2 (en) | 2005-04-01 | 2012-11-13 | Qiagen Gmbh | Reverse transcription and amplification of RNA with simultaneous degradation of DNA |
US7449297B2 (en) * | 2005-04-14 | 2008-11-11 | Euclid Diagnostics Llc | Methods of copying the methylation pattern of DNA during isothermal amplification and microarrays |
EP2204454A1 (de) * | 2005-05-04 | 2010-07-07 | University of South Florida | Vorhersage der Reaktion auf Behandlungen von Krebspatienten |
US20060269929A1 (en) * | 2005-05-26 | 2006-11-30 | Hall Gerald E Jr | Methods and kits for DNA purification on polymeric membranes at low ionic strength |
US20060270843A1 (en) * | 2005-05-26 | 2006-11-30 | Hall Gerald E Jr | Methods for isolation of nucleic acids |
US7544471B2 (en) | 2005-07-30 | 2009-06-09 | Agilent Technologies, Inc. | Preparing RNA from a wax-embedded tissue specimen |
US20070054168A1 (en) * | 2005-09-06 | 2007-03-08 | Hao Chang | Zinc/air cell |
EP1762627A1 (de) | 2005-09-09 | 2007-03-14 | Qiagen GmbH | Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion |
EP1777291A1 (de) * | 2005-10-20 | 2007-04-25 | Fundacion para la Investigacion Clinica y Molecular del Cancer de Pulmon | Verfahren zur Isolierung von mRNS aus Formalin-fixierten, Paraffin-eingebetteten Gewebeproben |
US20070092883A1 (en) * | 2005-10-26 | 2007-04-26 | De Luwe Hoek Octrooien B.V. | Methylation specific multiplex ligation-dependent probe amplification (MS-MLPA) |
DE102005060738A1 (de) * | 2005-12-16 | 2007-06-21 | Qiagen Gmbh | Verfahren zur Extraktion von Biomolekülen aus fixierten Geweben |
CN100366632C (zh) * | 2005-12-28 | 2008-02-06 | 南方医科大学 | 一种石蜡包埋组织提取蛋白质的方法 |
WO2008057305A2 (en) * | 2006-10-27 | 2008-05-15 | George Mason Intellectual Properties, Inc. | Assay for metastatic colorectal cancer |
WO2008135196A1 (en) * | 2007-05-03 | 2008-11-13 | Roche Diagnostics Gmbh | SINGLE-CELL mRNA QUANTIFICATION WITH REAL-TIME RT-PCR |
WO2008157316A1 (en) * | 2007-06-14 | 2008-12-24 | Creighton University | Improved method for rna isolation |
BRPI0813364A2 (pt) * | 2007-06-15 | 2014-12-30 | Univ South Florida | Métodos de diagnóstico e tratamento de câncer. |
WO2009002937A2 (en) | 2007-06-22 | 2008-12-31 | Response Genetics, Inc | Methods for isolating long fragment rna from fixed samples |
CN101910414B (zh) | 2007-11-07 | 2016-01-13 | 健泰科生物技术公司 | 用于评估b细胞淋巴瘤对抗cd40抗体治疗的响应性的方法和组合物 |
WO2009127350A1 (en) * | 2008-04-15 | 2009-10-22 | Universität Bern | Method for optimized isolation of rna from fixed tissue |
US20090298172A1 (en) * | 2008-05-28 | 2009-12-03 | Steven Paul Wheeler | Histological specimen treatment apparatus and method |
DE102008029356A1 (de) * | 2008-06-20 | 2009-12-24 | Siemens Healthcare Diagnostics Gmbh | Verfahren zur Aufreinigung von Nukleinsäuren, insbesondere aus fixiertem Gewebe |
CN102112631A (zh) * | 2008-08-01 | 2011-06-29 | 霍夫曼-拉罗奇有限公司 | 用于mRNA扩增的改进的裂解和逆转录 |
EP2370803A2 (de) * | 2008-12-03 | 2011-10-05 | The United States Government As Represented By The Department Of Veterans Affairs | Druckunterstützte molekulare wiederherstellung wie von biomolekülen, druckunterstützte antigenrückgewinnung und druckunterstützte gewebehistologie |
EP2193831A1 (de) | 2008-12-05 | 2010-06-09 | Qiagen GmbH | Parallel-Extraktion von unterschiedlichen Biomolekülen aus Formalin-fixiertem Gewebe |
DE102008061714A1 (de) | 2008-12-12 | 2010-06-17 | Siemens Healthcare Diagnostics Inc., Deerfield | Verfahren zur Aufreinigung von Nukleinsäuren, inbesondere aus fixiertem Gewebe |
US8846878B1 (en) | 2009-01-23 | 2014-09-30 | Cubrc Corporation | Method and device for isolating a protein sample |
EP2210936A1 (de) * | 2009-01-27 | 2010-07-28 | Curetis AG | Verarbeitung und Analyse von viskosen, flüssigen biologischen Proben |
JP5836929B2 (ja) * | 2009-04-18 | 2015-12-24 | ジェネンテック, インコーポレイテッド | 抗cd40抗体を用いる治療に対するb細胞性リンパ腫の応答性を評価するための方法 |
US20120100997A1 (en) | 2009-04-24 | 2012-04-26 | University Of Southern California | Cd133 polymorphisms and expression predict clinical outcome in patients with cancer |
DE102009031434B4 (de) | 2009-07-01 | 2015-03-05 | Axagarius Gmbh & Co. Kg | Verwendung eines Kits für die Isolierung von Biomolekülen aus biologischen Proben sowie Kit hierfür |
JP5932648B2 (ja) | 2009-09-23 | 2016-06-15 | ダニスコ・ユーエス・インク | 新規なグリコシルヒドロラーゼ酵素及びその用途 |
US8329360B2 (en) | 2009-12-04 | 2012-12-11 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method and apparatus of providing overlay |
US10138499B2 (en) | 2009-12-23 | 2018-11-27 | Danisco Us Inc. | Methods for improving the efficiency of simultaneous saccharification and fermentation reactions |
EP2521778B1 (de) * | 2010-01-04 | 2014-03-19 | QIAGEN Gaithersburg, Inc. | Verfahren, zusammensetzungen und kits zur gewinnung von nukleinsäuren oder proteinen aus festen gewebeproben |
EP2539449B9 (de) | 2010-02-26 | 2018-09-05 | Qiagen GmbH | Verfahren zur parallelen isolierung und/oder aufreinigung von rna und dna |
US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
EP3399036B1 (de) | 2010-04-08 | 2023-01-25 | QIAGEN GmbH | Chromatografische vorrichtung und verfahren zur isolierung und reinigung von nukleinsäuren |
EP2556143B1 (de) | 2010-04-08 | 2016-12-07 | Qiagen GmbH | Verfahren zum isolieren und reinigen von nukleinsäuren |
EP2558595A2 (de) | 2010-04-12 | 2013-02-20 | Response Genetics, Inc | Kras-primer und -sonden |
EP2388324A1 (de) * | 2010-05-20 | 2011-11-23 | Siemens Healthcare Diagnostics Inc. | Kontrollmaterial für Nukleinsäureteste |
EP2395082A1 (de) * | 2010-06-14 | 2011-12-14 | QIAGEN GmbH | Extraktion von Nukleinsäuren aus in Wachs eingebetteten Proben |
WO2012051332A1 (en) | 2010-10-12 | 2012-04-19 | Life Technologies Corporation | Method of preparing quality control material for ffpe |
KR101420094B1 (ko) * | 2010-10-27 | 2014-07-17 | (주)바이오니아 | 다양한 생체시료분석을 위한 전자동실시간정량증폭장비, 다양한 생체시료분석을 위한 자동정제 및 반응준비 장치, 전자동 핵산정제 및 실시간 정량 유전자증폭 방법, 전자동 핵산정제방법, 실시간정량pcr을 이용한 병원균의 전자동 생균수검사방법, 정량면역pcr을 이용한 전자동 항원농도획득방법 및 타겟항원에 라벨링된 부착용 타겟핵산의 정제방법 |
TWI425977B (zh) | 2010-11-24 | 2014-02-11 | Ind Tech Res Inst | 將福馬林固定石蠟包埋之組織進行脫蠟的方法與其套組 |
EP2468862A1 (de) | 2010-12-23 | 2012-06-27 | Qiagen GmbH | Verfahren und Kit zur Verarbeitung von in Wachs eingebetteten biologischen Proben |
CN102146112B (zh) * | 2011-01-25 | 2013-07-10 | 天根生化科技(北京)有限公司 | 从福尔马林固定石蜡包埋组织中提取脱氧核糖核酸的方法 |
CN107255584B (zh) * | 2011-02-28 | 2021-04-13 | 安捷伦科技有限公司 | 用于预处理包埋的生物样本的不混溶两相系统 |
CN102181431B (zh) * | 2011-03-11 | 2012-12-26 | 大连医科大学 | 从石蜡包埋组织中提取总rna的方法 |
DK2686434T3 (da) | 2011-03-17 | 2021-10-11 | Danisco Us Inc | Fremgangsmåde til reduktion af viskositet i saccharificeringsproces |
JP6273198B2 (ja) * | 2011-03-28 | 2018-01-31 | ジェロン・コーポレーションGeron Corporation | 定量的pcrによる、ホルマリン固定パラフィン包埋(ffpe)試料におけるテロメア長測定 |
GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
WO2013010074A1 (en) | 2011-07-13 | 2013-01-17 | Primeradx, Inc. | Multimodal methods for simultaneous detection and quantification of multiple nucleic acids in a sample |
FR2982278A1 (fr) | 2011-11-03 | 2013-05-10 | Assist Publ Hopitaux De Paris | Procede de classification d'echantillons de tissus fixes et inclus en paraffine |
US9416357B2 (en) | 2011-11-16 | 2016-08-16 | University Of Georgia Research Foundation, Inc. | Method for isolating total RNA from cells |
WO2013074885A1 (en) | 2011-11-17 | 2013-05-23 | Rheonix, Inc. | Microfluidic apparatus, method, and applications |
CN103571824B (zh) | 2012-08-09 | 2016-04-13 | 财团法人工业技术研究院 | 用于分离核酸的组合物及方法 |
ES2843202T3 (es) | 2012-09-28 | 2021-07-16 | Cepheid | Métodos para la extracción de ADN y ARN a partir de muestras de tejido fijado embebido en parafina |
CA2887575A1 (en) | 2012-10-15 | 2014-04-24 | Pioneer Hi-Bred International, Inc. | Methods and compositions to enhance activity of cry endotoxins |
US10968446B2 (en) | 2012-11-01 | 2021-04-06 | Massachusetts Institute Of Technology | Directed evolution of synthetic gene cluster |
EP2730653A1 (de) | 2012-11-07 | 2014-05-14 | QIAGEN GmbH | Verfahren zum Lysieren einer festen biologischen Probe |
US9200327B2 (en) | 2012-11-30 | 2015-12-01 | Geron Corporation | Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors |
CA3200166A1 (en) | 2013-03-14 | 2014-09-25 | Pioneer Hi-Bred International, Inc. | Compositions and methods to control insect pests |
WO2014150914A2 (en) | 2013-03-15 | 2014-09-25 | Pioneer Hi-Bred International, Inc. | Phi-4 polypeptides and methods for their use |
KR101748867B1 (ko) * | 2013-04-19 | 2017-06-20 | 주식회사 젠큐릭스 | 조기 유방암 예후 예측 진단용 자동화 시스템 |
CN105849275B (zh) | 2013-06-25 | 2020-03-17 | 普罗格诺西斯生物科学公司 | 检测样品中生物靶标的空间分布的方法和系统 |
EA030896B1 (ru) | 2013-08-16 | 2018-10-31 | Пайонир Хай-Бред Интернэшнл, Инк. | Инсектицидные белки и способы их применения |
US10667524B2 (en) | 2013-09-13 | 2020-06-02 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
WO2015120276A1 (en) | 2014-02-07 | 2015-08-13 | Pioneer Hi Bred International Inc | Insecticidal proteins and methods for their use |
WO2015120270A1 (en) | 2014-02-07 | 2015-08-13 | Pioneer Hi Bred International, Inc. | Insecticidal proteins and methods for their use |
WO2016000237A1 (en) | 2014-07-03 | 2016-01-07 | Pioneer Overseas Corporation | Plants having enhanced tolerance to insect pests and related constructs and methods involving insect tolerance genes |
WO2016044092A1 (en) | 2014-09-17 | 2016-03-24 | Pioneer Hi Bred International Inc | Compositions and methods to control insect pests |
UA126192C2 (uk) | 2014-10-16 | 2022-08-31 | Піонір Хай-Бред Інтернешнл, Інк. | Інсектицидний білок та спосіб його застосування |
DE102014118532B4 (de) | 2014-12-12 | 2017-03-23 | Axagarius Gmbh & Co. Kg | Vorrichtung mit einer Filterschicht und Verfahren zur Gewinnung von Nukleinsäuren aus Formalin-fixierten und in Paraffin eingebetteten Proben |
WO2016109799A2 (en) * | 2014-12-31 | 2016-07-07 | The Rockefeller University | Method of rna isolation from clinical samples |
US10876132B2 (en) | 2015-03-11 | 2020-12-29 | Pioneer Hi-Bred International, Inc. | Insecticidal combinations of PIP-72 and methods of use |
EP4119677B1 (de) | 2015-04-10 | 2023-06-28 | Spatial Transcriptomics AB | Räumlich getrennte multiplex-nukleinsäureanalyse von biologischen proben |
US10365189B2 (en) | 2015-05-07 | 2019-07-30 | Steven Wheeler | Histological specimen treatment |
RU2017144238A (ru) | 2015-05-19 | 2019-06-19 | Пайонир Хай-Бред Интернэшнл, Инк. | Инсектицидные белки и способы их применения |
EA033170B1 (ru) * | 2015-05-21 | 2019-09-30 | Государственное Учреждение Образования "Белорусская Медицинская Академия Последипломного Образования" (Гуо "Белмапо") | Способ определения экспрессии гена gstm1 в образцах из парафин-фиксированных срезов опухолевой ткани молочной железы |
CA2986265A1 (en) | 2015-06-16 | 2016-12-22 | Pioneer Hi-Bred International, Inc. | Compositions and methods to control insect pests |
RU2769873C2 (ru) | 2015-07-13 | 2022-04-07 | Пивот Байо, Инк. | Способы и композиции для улучшения признаков растений |
DK3325647T3 (da) | 2015-07-24 | 2020-05-18 | Cepheid | Sammensætninger og fremgangsmåder til dna- og rna-ekstraktion fra vævsprøver |
ES2926808T3 (es) | 2015-08-06 | 2022-10-28 | Pioneer Hi Bred Int | Proteínas insecticidas derivadas de plantas y métodos para su uso |
CA2992488A1 (en) | 2015-08-28 | 2017-03-09 | Pioneer Hi-Bred International, Inc. | Ochrobactrum-mediated transformation of plants |
JP2018537119A (ja) | 2015-10-05 | 2018-12-20 | マサチューセッツ インスティテュート オブ テクノロジー | リファクターされたnifクラスターを使用する窒素固定 |
KR101749419B1 (ko) | 2015-10-15 | 2017-07-03 | 주식회사 어큐진 | 파라핀포매된 샘플로부터 dna를 추출하는 방법 |
NZ741539A (en) | 2015-11-06 | 2024-03-22 | Ventana Med Syst Inc | Representative diagnostics |
EP3390431A1 (de) | 2015-12-18 | 2018-10-24 | Pioneer Hi-Bred International, Inc. | Insektizide proteine und verfahren zu deren verwendung |
BR112018070754A2 (pt) | 2016-04-14 | 2019-02-12 | Pioneer Hi-Bred International, Inc. | polipeptídeos, polinucleotídeos, construção de dna, célula hospedeira, plantas ou célula vegetal, semente, composição, método para controlar uma população de pragas lepidópteras, método para exterminar uma praga de lepidóptero, método para produzir um polipeptídeo com atividade pesticida e método para proteger uma planta contra uma praga de inseto |
CN109072249B (zh) | 2016-04-19 | 2023-08-18 | 先锋国际良种公司 | 具有改善的活性谱的多肽的杀昆虫组合及其用途 |
US11008585B2 (en) | 2016-05-04 | 2021-05-18 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
CN109312359A (zh) | 2016-06-16 | 2019-02-05 | 先锋国际良种公司 | 用以防治昆虫有害生物的组合物和方法 |
UA127388C2 (uk) | 2016-06-24 | 2023-08-09 | Піонір Хай-Бред Інтернешнл, Інк. | Регуляторний елемент рослини і спосіб його застосування |
MX2018015906A (es) | 2016-07-01 | 2019-04-04 | Pioneer Hi Bred Int | Proteinas insecticidas de plantas y metodos para sus usos. |
WO2018013333A1 (en) | 2016-07-12 | 2018-01-18 | Pioneer Hi-Bred International, Inc. | Compositions and methods to control insect pests |
CA3038806A1 (en) | 2016-11-01 | 2018-05-11 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
BR112019012339A2 (pt) | 2016-12-14 | 2019-11-26 | Pioneer Hi Bred Int | polipeptídeo inseticida recombinante, composição, construto de dna, célula hospedeira, planta transgênica, método para inibir o crescimento ou extermínio de uma praga de inseto ou população de praga, polipeptídeo ipd093 quimérico e proteína de fusão |
EP3559271A1 (de) * | 2016-12-22 | 2019-10-30 | Ventana Medical Systems, Inc. | Vollautomatisches nukleinsäureextraktionsverfahren für gewebeproben |
EP3558004A1 (de) | 2016-12-22 | 2019-10-30 | Pioneer Hi-Bred International, Inc. | Insektizide proteine und verfahren zu deren verwendung |
EP3568385A4 (de) | 2017-01-12 | 2021-03-03 | Pivot Bio, Inc. | Verfahren und zusammensetzungen zur verbesserung von pflanzeneigenschaften |
WO2018140214A1 (en) | 2017-01-24 | 2018-08-02 | Pioneer Hi-Bred International, Inc. | Nematicidal protein from pseudomonas |
US20190390219A1 (en) | 2017-02-08 | 2019-12-26 | Pioneer Hi-Bred International, Inc. | Insecticidal combinations of plant derived insecticidal proteins and methods for their use |
EP3630982A1 (de) | 2017-05-26 | 2020-04-08 | Pioneer Hi-Bred International, Inc. | Insektizide polypeptide mit verbessertem wirkungsspektrum und verwendungen davon |
CN107271239A (zh) * | 2017-07-06 | 2017-10-20 | 浙江大学 | 一种溶解石蜡组织切片的方法及应用 |
US20200165626A1 (en) | 2017-10-13 | 2020-05-28 | Pioneer Hi-Bred International, Inc. | Virus-induced gene silencing technology for insect control in maize |
MX2020004343A (es) | 2017-10-25 | 2021-01-08 | Pivot Bio Inc | Métodos y composiciones para mejorar microbios modificados que fijan nitrógeno. |
WO2019165245A1 (en) | 2018-02-22 | 2019-08-29 | Zymergen Inc. | Method for creating a genomic library enriched for bacillus and identification of novel cry toxins |
US20210002657A1 (en) | 2018-03-02 | 2021-01-07 | Pioneer Hi-Bred International, Inc. | Plant health assay |
CN111770995A (zh) | 2018-03-02 | 2020-10-13 | 齐默尔根公司 | 杀昆虫蛋白发现平台和自其发现的杀昆虫蛋白 |
CA3096516A1 (en) | 2018-05-22 | 2019-11-28 | Pioneer Hi-Bred International, Inc. | Plant regulatory elements and methods of use thereof |
AU2019291824A1 (en) | 2018-06-27 | 2021-01-14 | Pivot Bio, Inc. | Agricultural compositions comprising remodeled nitrogen fixing microbes |
US11878999B2 (en) | 2018-08-29 | 2024-01-23 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
WO2020123309A1 (en) | 2018-12-10 | 2020-06-18 | 10X Genomics, Inc. | Resolving spatial arrays by proximity-based deconvolution |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
EP3976820A1 (de) | 2019-05-30 | 2022-04-06 | 10X Genomics, Inc. | Verfahren zum nachweis der räumlichen heterogenität einer biologischen probe |
CN110376036A (zh) * | 2019-07-30 | 2019-10-25 | 河南赛诺特生物技术有限公司 | 一种肿瘤细胞系免疫组化对照品的制备方法及肿瘤细胞系免疫组化对照品 |
CN110361242B (zh) * | 2019-08-14 | 2022-01-18 | 武汉赛维尔生物科技有限公司 | 一种用于眼球组织的固定液以及眼球组织制片的预处理方法 |
WO2021076346A1 (en) | 2019-10-18 | 2021-04-22 | Pioneer Hi-Bred International, Inc. | Maize event dp-202216-6 and dp-023211-2 stack |
EP4025711A2 (de) | 2019-11-08 | 2022-07-13 | 10X Genomics, Inc. | Erhöhung der spezifität einer analytbindung |
WO2021133849A1 (en) | 2019-12-23 | 2021-07-01 | 10X Genomics, Inc. | Methods for spatial analysis using rna-templated ligation |
EP4081656A1 (de) | 2019-12-23 | 2022-11-02 | 10X Genomics, Inc. | Zusammensetzungen und verfahren zur verwendung von fixierten biologischen proben bei partitionsbasierten tests |
EP4081777A1 (de) | 2019-12-23 | 2022-11-02 | 10X Genomics, Inc. | Reversible fixierreagenzien und verfahren zur verwendung davon |
US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
TW202142114A (zh) | 2020-02-04 | 2021-11-16 | 美商陶氏農業科學公司 | 具有殺有害生物效用之組成物及與其相關之方法 |
US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
EP4127164A1 (de) | 2020-03-31 | 2023-02-08 | QIAGEN GmbH | Nukleinsäurereinigung aus fixierten biologischen proben |
WO2021207610A1 (en) | 2020-04-10 | 2021-10-14 | 10X Genomics, Inc. | Cold protease treatment method for preparing biological samples |
WO2021212042A1 (en) | 2020-04-16 | 2021-10-21 | 10X Genomics, Inc. | Compositions and methods for use with fixed samples |
EP4242325A3 (de) | 2020-04-22 | 2023-10-04 | 10X Genomics, Inc. | Verfahren zur räumlichen analyse unter verwendung von gezieltem rna-abbau |
WO2021236929A1 (en) | 2020-05-22 | 2021-11-25 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
AU2021275906A1 (en) | 2020-05-22 | 2022-12-22 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
EP4162074B1 (de) | 2020-06-08 | 2024-04-24 | 10X Genomics, Inc. | Verfahren zur bestimmung eines chirurgischen randes und verfahren zur verwendung davon |
CN116034166A (zh) | 2020-06-25 | 2023-04-28 | 10X基因组学有限公司 | Dna甲基化的空间分析 |
US11981960B1 (en) | 2020-07-06 | 2024-05-14 | 10X Genomics, Inc. | Spatial analysis utilizing degradable hydrogels |
US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
US20230235352A1 (en) | 2020-07-14 | 2023-07-27 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
CN116323968A (zh) | 2020-07-31 | 2023-06-23 | 10X基因组学有限公司 | 用于空间分析的去交联化合物和使用方法 |
CA3189603A1 (en) | 2020-08-10 | 2022-01-17 | Pioneer Hi-Bred International, Inc. | Plant regulatory elements and methods of use thereof |
US11981958B1 (en) | 2020-08-20 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using DNA capture |
US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
WO2022103712A1 (en) | 2020-11-13 | 2022-05-19 | 10X Genomics, Inc. | Nano-partitions (encapsulated nucleic acid processing enzymes) for cell-lysis and multiple reactions in partition-based assays |
US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
EP4121555A1 (de) | 2020-12-21 | 2023-01-25 | 10X Genomics, Inc. | Verfahren, zusammensetzungen und systeme zur erfassung von sonden und/oder barcodes |
CN114854824A (zh) * | 2021-02-03 | 2022-08-05 | 深圳华大基因股份有限公司 | 建库方法及应用 |
US20230071935A1 (en) * | 2021-08-25 | 2023-03-09 | Matchstick Technologies, Inc. | Microplate cycling thermo sonicator with programmable ultrasound, heating, and cooling for multi-analytical applications |
EP4196605A1 (de) | 2021-09-01 | 2023-06-21 | 10X Genomics, Inc. | Verfahren, zusammensetzungen und kits zur blockierung einer erfassungssonde auf einer räumlichen anordnung |
TW202345696A (zh) | 2022-05-18 | 2023-12-01 | 美商科迪華農業科技有限責任公司 | 具有殺有害生物效用之組成物及與其相關的方法 |
WO2023245190A1 (en) | 2022-06-17 | 2023-12-21 | 10X Genomics, Inc. | Catalytic de-crosslinking of samples for in situ analysis |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4830969A (en) | 1981-08-31 | 1989-05-16 | The Research Foundation Of State University Of New York | Process for the rapid and simple isolation of nucleic acids |
US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
US5128247A (en) | 1989-08-14 | 1992-07-07 | Board Of Regents, The University Of Texas System | Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources |
US5620852A (en) | 1990-11-14 | 1997-04-15 | Hri Research, Inc. | Nucleic acid preparation methods |
US5654179A (en) * | 1990-11-14 | 1997-08-05 | Hri Research, Inc. | Nucleic acid preparation methods |
US5284940A (en) | 1990-11-14 | 1994-02-08 | Hri Research, Inc. | Preparation for nucleic acid samples |
US5346994A (en) * | 1992-01-28 | 1994-09-13 | Piotr Chomczynski | Shelf-stable product and process for isolating RNA, DNA and proteins |
US5502166A (en) | 1992-02-26 | 1996-03-26 | Mitsubishi Chemical Corporation | NMDH receptor proteins and genes encoding the same |
AU6230594A (en) | 1993-02-01 | 1994-08-29 | University Of Iowa Research Foundation, The | Quartenary amine surfactants and methods of using same in isolation of rna |
US5876978A (en) * | 1993-04-06 | 1999-03-02 | Medical College Of Ohio | Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
US5637687A (en) | 1993-08-31 | 1997-06-10 | Wiggins; James C. | Methods and compositions for isolating nucleic acids |
US5643767A (en) | 1994-05-02 | 1997-07-01 | The Rockefeller University | Process for isolating cellular components |
US5942391A (en) * | 1994-06-22 | 1999-08-24 | Mount Sinai School Of Medicine | Nucleic acid amplification method: ramification-extension amplification method (RAM) |
US5876924A (en) * | 1994-06-22 | 1999-03-02 | Mount Sinai School Of Medicine | Nucleic acid amplification method hybridization signal amplification method (HSAM) |
CA2153215A1 (en) | 1994-07-06 | 1996-01-07 | Lu Wang | Treatment of paraffin embedded tissue for gene analysis |
US5707802A (en) * | 1995-01-13 | 1998-01-13 | Ciba Corning Diagnostics Corp. | Nucleic acid probes for the detection and identification of fungi |
US5763169A (en) * | 1995-01-13 | 1998-06-09 | Chiron Diagnostics Corporation | Nucleic acid probes for the detection and identification of fungi |
US5777099A (en) | 1995-02-24 | 1998-07-07 | Biotecx Laboratories, Inc. | RNA separation |
US5945515A (en) | 1995-07-31 | 1999-08-31 | Chomczynski; Piotr | Product and process for isolating DNA, RNA and proteins |
US5998151A (en) | 1995-12-01 | 1999-12-07 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for predicting the efficacy of a chemotherapeutic regimen for gastrointestinal cancers using antibodies specific for thymidylate synthase |
US20020090642A1 (en) * | 1995-12-11 | 2002-07-11 | Patrick G. Johnston | Methods for determining the prognosis of breast cancer using antibodies specific for thymidylate synthase |
DE29601618U1 (de) | 1996-01-31 | 1996-07-04 | InViTek GmbH, 13125 Berlin | Vorrichtung zur gleichzeitigen multiplen Isolierung |
EP0791654A1 (de) | 1996-02-21 | 1997-08-27 | Jürgen A. Dr. Richt | Polypeptide, die Aminosäuresequenzen der p57 oder p9.5 Proteine aus Borna-Krankheit Virus entsprechen, dafür kodierende Nukleinsäurefragmente und ihre Verwendung zu Diagnose- und Immunisierungzwecke |
WO1997043407A1 (en) | 1996-05-10 | 1997-11-20 | Phylomed Corporation | Methods for oxidizing disulfide bonds using ozone |
WO1998044159A1 (en) * | 1997-03-31 | 1998-10-08 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the gastrointestinal tract |
ATE314488T1 (de) * | 1999-03-18 | 2006-01-15 | Exiqon As | Einstufige probezubereitung und bestimmung von nukleinsäure in biologischen proben |
US6248535B1 (en) * | 1999-12-20 | 2001-06-19 | University Of Southern California | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
-
1999
- 1999-12-20 US US09/469,338 patent/US6248535B1/en not_active Expired - Lifetime
-
2000
- 2000-10-31 DE DE60032634T patent/DE60032634T2/de not_active Expired - Lifetime
- 2000-10-31 BR BR0016569-7A patent/BR0016569A/pt not_active Application Discontinuation
- 2000-10-31 KR KR1020027007849A patent/KR100723328B1/ko not_active IP Right Cessation
- 2000-10-31 EA EA200501772A patent/EA008832B1/ru not_active IP Right Cessation
- 2000-10-31 WO PCT/US2000/030012 patent/WO2001046402A1/en active IP Right Grant
- 2000-10-31 EP EP00978311A patent/EP1242594B1/de not_active Expired - Lifetime
- 2000-10-31 AU AU15785/01A patent/AU784565C/en not_active Ceased
- 2000-10-31 JP JP2001546900A patent/JP2003525033A/ja active Pending
- 2000-10-31 AT AT00978311T patent/ATE349518T1/de active
- 2000-10-31 CA CA2394618A patent/CA2394618C/en not_active Expired - Fee Related
- 2000-10-31 EA EA200200698A patent/EA006827B1/ru not_active IP Right Cessation
- 2000-10-31 IL IL15011600A patent/IL150116A0/xx unknown
- 2000-10-31 DK DK06123097.5T patent/DK1743939T3/da active
- 2000-10-31 MX MXPA02006145A patent/MXPA02006145A/es active IP Right Grant
- 2000-10-31 EP EP06123097A patent/EP1743939B1/de not_active Expired - Lifetime
- 2000-10-31 CN CN200610093878XA patent/CN1891836B/zh not_active Expired - Fee Related
- 2000-10-31 CN CNB008174741A patent/CN1269959C/zh not_active Expired - Fee Related
- 2000-10-31 EP EP10182481.1A patent/EP2363477A3/de not_active Withdrawn
- 2000-10-31 AT AT06123097T patent/ATE523590T1/de active
- 2000-10-31 ES ES06123097T patent/ES2373149T3/es not_active Expired - Lifetime
- 2000-12-20 AR ARP000106793A patent/AR027036A1/es active IP Right Grant
- 2000-12-20 TW TW089127378A patent/TWI277652B/zh not_active IP Right Cessation
-
2001
- 2001-03-01 US US09/797,216 patent/US6613518B2/en not_active Expired - Lifetime
- 2001-03-01 US US09/797,158 patent/US6428963B2/en not_active Expired - Lifetime
- 2001-03-01 US US09/797,163 patent/US6610488B2/en not_active Expired - Lifetime
-
2002
- 2002-06-10 IL IL150116A patent/IL150116A/en not_active IP Right Cessation
- 2002-06-19 NO NO20022945A patent/NO330802B1/no not_active IP Right Cessation
-
2003
- 2003-07-08 US US10/616,203 patent/US20040091910A1/en not_active Abandoned
- 2003-07-30 US US10/631,413 patent/US7960147B2/en not_active Expired - Fee Related
- 2003-10-28 HK HK03107749A patent/HK1055446A1/xx not_active IP Right Cessation
-
2006
- 2006-04-05 US US11/278,804 patent/US7998707B2/en not_active Expired - Fee Related
- 2006-07-12 AU AU2006202986A patent/AU2006202986B2/en not_active Ceased
-
2007
- 2007-04-26 HK HK07104456.2A patent/HK1098178A1/xx not_active IP Right Cessation
- 2007-07-27 US US11/881,625 patent/US7919280B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO330802B1 (no) | Metode for gjenvinning av RNA fra formalin-fiksert paraffin-innstopt vevsprove, metode for kvantitativ maling av genekspresjon av et malgen og metode for maling av niva av malgenekspresjon i en fiksert paraffin-innstopt vevsprove. | |
US11965156B2 (en) | RNA isolation from soluble urine fractions | |
US9309559B2 (en) | Simultaneous extraction of DNA and RNA from FFPE tissues | |
CA2626533C (en) | Method for the isolation of mrna from formalin fixed, paraffin-embedded tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |